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CCL2 is an important inflammatory chemokine involved inmonocyte recruitment to inflamed tissues.The extracellular nucleotide
signalling molecules UTP and ATP acting via the P2Y2 receptor are known to induce CCL2 secretion in macrophages. We
confirmed this in the human THP-1 monocytic cell line showing that UTP is as efficient as LPS at inducing CCL2 at early time
points (2–6 hours). Expression and calcium mobilisation experiments confirmed the presence of functional P2Y2 receptors on
THP-1 cells. UTP stimulation of human peripheral CD14+ monocytes showed low responses to LPS (4-hour stimulation) but a
significant increase above background following 6 hours of treatment. The response to UTP in human monocytes was variable
and required stimulation >6 hours. With such variability in response we looked for single nucleotide polymorphisms in P2RY2
that could affect the functional response. Sequencing of P2RY2 from THP-1 cells revealed the presence of a single nucleotide
polymorphism altering amino acid 312 from arginine to serine (rs3741156).This polymorphism is relatively common at a frequency
of 0.276 (𝑛 = 404 subjects). Finally, we investigated CCL2 secretion in response to LPS or UTP in human macrophages expressing
312Arg-P2Y2 or 312Ser-P2Y2 where only the latter exhibited significant UTP-induced CCL2 secretion (𝑛 = 5 donors per group).
1. Introduction
The CCL2/CCR2 mediated recruitment of monocytes is
necessary for fighting infections to microorganisms [1].
This chemokine signalling axis has also been implicated
in a number of inflammatory disorders where monocyte
infiltration is a key factor such as atherosclerosis, multiple
sclerosis, and rheumatoid arthritis [2]. Understanding the
cellular regulation of this important chemokine is therefore
critical for understanding some of the early pathophysiology
of inflammatory disorders.
P2Y receptors are members of the metabotropic family
of purinergic receptors belonging to the larger family of G-
protein coupled receptors. Eight subtypes of P2Y have been
identified to date—P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12,
P2Y13, and P2Y14—with differences in both pharmacology
and downstream signalling pathways [3, 4]. P2Y2 has a
widespread distribution in the body including expression on
glial cells, some neurons, endothelial cells, epithelial cells of
many tissues, and myeloid immune cells including mono-
cytes, macrophages, and dendritic cells [5–10]. Many studies
have demonstrated activation of P2Y2 induces a transient
calcium response [11, 12] but much less is known about
the regulation of chemokine or cytokine production. Our
previous work was the first to demonstrate a role for the P2Y2
receptor in regulation of CCL2 secretion from alveolar and
peritoneal macrophages [10]. P2Y2 and the UDP-responsive
P2Y6 receptor can also signal other chemokine productions
including CXCL8 (IL-8) and CCL20 (MIP-3𝛼) [9, 13, 14].
Knockout mouse studies have demonstrated that P2Y2 plays
an important role in defence against lung infection with
Pseudomonas aeruginosa [15] yet it can also play a role in
allergic lung inflammation in various models [16, 17].
Extracellular nucleotide induction of CCL2 in cells
expressing P2Y2 could be an important trigger for the
initial recruitment of monocytes to an inflammatory site.
Many inducers have been identified for CCL2 including
lipopolysaccharide (LPS), growth factors such as platelet
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derived growth factor (PDGF), and cytokines such as tumour
necrosis factor-alpha (TNF-𝛼), reviewed in [18]. Following
tissue/cellular damage or regulated nucleotide release from
cells or nerve terminals, the activation of P2Y2 by extra-
cellular nucleotides could switch on a rapid production of
CCL2. Whilst this may be beneficial for initiating repair to
an injured site, uncontrolled or chronic nucleotide release
may be detrimental and cause excessive tissue inflammation.
Both ATP and UTP are known danger signals and act as
immunomodulatory signals to communicate alarmmessages
to immune cells.
The aim of this study was to investigate extracellu-
lar nucleotide-induced chemokine production in human
macrophages and monocytes with an emphasis on CCL2.
Firstly we wanted to confirm our earlier findings in rodent
alveolar macrophages using a humanmonocyte/macrophage
cell line and secondly we wanted to compare P2Y2 induced
CCL2 secretion with that of LPS, a known bacterial inducer
of CCL2. Finally we wanted to perform a pilot study to
determine whether we could measure nucleotide-induced
CCL2 secretion from primary human cells and assess the
responses to both P2Y2 agonists and LPS.
2. Materials and Methods
2.1. Materials. UTP, ATP, suramin, and LPS (strain 055:B5)
were from Sigma-Aldrich (Ryde, Australia). 2-thio-UTP
and UTP𝛾S were from Tocris Biosciences (Bristol, UK).
Interferon 𝛾 (IFN-𝛾) was from Roche Diagnostics. MwoI
restriction enzyme was from NEB.
2.2. Cell Culture. The THP-1 monocytic cell line was main-
tained in RPMI 1640 media (Life Technologies) containing
10% foetal bovine serum (US origin, Lonza), 2mM L-
glutamine, 100U/mL penicillin, and 100𝜇g/mL streptomycin
(all Life Technologies) and grown under humidified condi-
tions in a 5% CO
2
incubator. Cells were routinely passaged
every 2-3 days. For differentiation to macrophages, THP-1
cells were plated at 1×106 cells/well in 24-well plates in 500𝜇L
completemedium and stimulatedwith 1000U/mL IFN-𝛾 and
100 ng/mL LPS for 48 hours.
2.3. Human Monocyte Preparation. Peripheral venous blood
was collected in lithium heparin tubes (Becton Dickin-
son) from healthy volunteers with informed consent (study
approved by Nepean Blue Mountains Local Health Service
Human Ethics committee). Mononuclear cells were isolated
by Ficoll-Paque (GE Healthcare) gradient centrifugation
and monocytes were isolated using CD14 microbeads and
LS columns on a midiMACS system (Miltenyi Biotech,
Germany) as per manufacturer’s instructions. The purity
for CD14 monocyte isolations was routinely >90% by flow
cytometry.
Formacrophage experiments, peripheral bloodmononu-
clear cells were plated in complete RPMI 1640 medium at a
density of 2.5 × 106 cells per well. Cells were incubated for
2 hours at 37∘C in order to adhere to plastic, nonadherent
cells removed, and adherent PBMCs were cultured overnight
in 1mL complete media, washed once the following day, and
cultured for 6 more days.
2.4. CalciumMeasurements. THP-1 cells were harvested from
flasks, pelleted at 300×g, and resuspended in Fluo-4 NW
assay buffer (Life Technologies). THP-1 cells were plated at
a density of 2 × 105 cells/well into a 96-well plate coated
with poly-D-lysine (Merck Millipore) and were loaded for
30 minutes at 37∘C. Human monocytes were plated at 2–
4 × 105 cells/well and prepared in the same way. Calcium
measurements were performed using a Fluostar OPTIMA
plate reader (BMG Labtech) with excitation at 485 nm and
emission at 520 nm. All measurements were made at 37∘C
using a gain setting of 40%.
2.5. ELISA Experiments. THP-1 cells were plated at 1 × 106
cells/well in a 24-well plate in RPMI 1640 media containing
1% serum (0.5mL per well). Stimulations were performed
in duplicate. LPS (1 or 10 𝜇g/mL) or nucleotides (varying
concentrations) were added directly into themedia for 2, 4, 6,
or 24 hours. Following stimulationmedia were removed from
the wells into Eppendorfs and centrifuged to remove any
contaminating cells. Supernatants were transferred to fresh
Eppendorfs and frozen at −80∘C. Freshly isolated human
peripheral blood CD14+ monocytes were plated at 5 × 105
cells/well in RPMI media containing 1% serum. Stimulations
were performed in duplicate/triplicate as for THP-1 cells and
cell-free supernatants collected after 4 or 6 hours.
Ninety-six well plates (NUNC) were coated with anti-
MCP-1 capture antibody (clone 10F7, BD Biosciences) at a
concentration of 2𝜇g/mL in sodium carbonate buffer pH
9.5. Samples and standards (recombinant human MCP-1)
were diluted in media. Detection antibody, anti-MCP-1-
biotin (clone 5D3-F7, BD Biosciences), was used at 0.5 𝜇g/mL
and followed by streptavidin-HRP at 1 𝜇g/mL. TMB-Ultra
(PerBioscience) was used for visualisation and 1MH
2
SO
4
was
used as stop solution. Absorbance at 450 nmwas read using a
BMG Labtech Optima plate reader. Standard curves were fit
with regression factor of 𝑟2 > 0.96.
2.6. Real-Time PCR. Cells were stimulated as described
above, collected into RNA Protect reagent (Qiagen), and
stored at −80∘C. Cells were then processed to extract total
RNA using an RNEasy Mini Kit (Qiagen). RNA concentra-
tions were measured using a spectrophotometer (Cary) using
absorbance at 260 nm. 1 𝜇g RNA was reverse transcribed
using a Tetro cDNA synthesis kit (Bioline) as per manufac-
turer’s instructions.
Primers for real-time PCR were optimised for concen-
trations over the range (0.125𝜇M to 1 𝜇M) and primer effi-
ciencieswere determined. Primer sequenceswere𝛽-actin for-
ward 5󸀠-GCC CTG GCA CCC AGC ACA AT-3󸀠 and reverse
5󸀠-GGAGGGGCCGGACTCGTCAT-3󸀠, GAPDH forward
5󸀠-CGA GAT CCC TCC AAA ATC AA-3󸀠 and reverse 5󸀠-
TTC ACA CCC ATG ACG AAC AT-3󸀠, CCL2 forward 5󸀠-
CCC CAG TCA CCT GCT GTT AT-3󸀠 and reverse 5󸀠-GAG
TTT GGG TTT GCT TGT CC-3󸀠, CCL20 forward 5󸀠-AAG
TTG TCT GTG TGC GCA AAT CC-3󸀠 and reverse 5󸀠-CCA
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TTC CAG AAA AGC CAC AGT TTT-3󸀠, CCL3 forward
5󸀠-ACT TTG AGA CGA GCA GCC AGTG-3󸀠 and reverse
5󸀠-TTT CTG GAC CCA CTC CTC ACTG-3󸀠, and CXCL8
forward 5󸀠-GAG AGT GAT TGA GAG TGG ACC AC-3󸀠
and reverse 5󸀠-CAC AAC CCT CTG CAC CCA GTT T-3󸀠.
Quantitative real-time PCR was performed using Sensimix
SYBR green No ROX mastermix (Bioline) and 0.75 𝜇M each
primer on freshly prepared cDNA. PCR were performed in
triplicate using a Rotorgene 2000 (Corbett Research) and
analysed using a threshold of 0.003 to determine Ct values.
Data was analysed using the 2−ΔΔCt method.
2.7. Flow Cytometry. One million THP-1 or peripheral blood
mononuclear cells were stained per flow tube. Cells were
fixed with 2% paraformaldehyde buffer for 20 minutes on
ice and permeabilised with 0.1% saponin in PBS. Rabbit
IgG was used as the negative control and anti-P2Y2 (Sigma)
was used at 1 : 100 dilution. Primary antibodies were incu-
bated for 30 minutes in PBS/0.1% saponin containing 5%
human AB serum. Cells were co-stained with mouse anti-
human CD14-FITC (1 : 100 dilution). PBMCs were washed
with PBS/saponin and incubated with goat anti-rabbit IgG-
Alexa 647 at 1 : 100 dilution for 30 minutes on ice. After
final washing with PBS/saponin, cells were resuspended in
PBS and 30000 events acquired on a BD FACSCalibur flow
cytometer. Monocytes were identified by CD14 expression
and plots of P2Y2-Alexa-647 staining were generated using
Weasel flow cytometry software (WEHI).
2.8. Genotyping. Genomic DNA was prepared from whole
blood as previously described [19] and stored at −80∘C. The
P2Y2 gene was amplified using 0.025U/mL recombinant Taq
DNApolymerase (Invitrogen), 1.5mMMgCl
2
, 100 𝜇MdNTP,
and 0.4 𝜇M each of forward and reverse primers. Primer
sequences were forward 5󸀠-CTT TTG CCG TCA TCC TTG
TCT-3󸀠 and reverse 5󸀠-CAT CTC GGG CAA AGC GTA-3󸀠
yielding a product of 328 bp.The following cycling conditions
were used: initial denaturation (95∘C for 3minutes), followed
by 40 cycles of denaturation (95∘C for 45 seconds), annealing
(55∘C for 30 seconds), and extension (72∘C for 30 seconds) on
a PTC-200 Peltier Thermal Cycler (MJ Research, Waltham,
Massachusetts, USA). The samples were then cooled at 4∘C
for 10 minutes.
A restriction assay was designed to determine the
sequence at nucleotide 1269, G, or C. Mutation from G>C
introduces an extra cut-site for the restriction enzymeMwoI.
P2Y2 PCR product was incubated with 3U MwoI for 1 hour
at 60∘C. Genomic DNA carrying G at nucleotide 1269 will
be cut at 2 positions yielding 3 fragments of 195 bp, 130 bp,
and 3 bp. Genomic DNA carrying C at nucleotide 1269 will be
cut at 3 positions yielding 4 fragments of 181 bp, 130 bp, 14 bp,
and 3 bp.The assay distinguishes between bands of 195 bp and
181 bp using a 3% agarose gel. Genotyping was verified using
a commercial high-throughput method assay for rs3741156
(AGRF, Brisbane).
2.9. Statistical Analysis. Data plotted are means ± SEM of
three to four experiments. Graphs and statistical analysis
were performed using GraphPad Prism version 5 (GraphPad
Software Inc., La Jolla, CA, USA).
3. Results
3.1. P2Y2 Regulates CCL2 Production in THP-1 Monocytes. It
has been demonstrated by others that THP-1 cells express
P2Y2 receptors [13, 20]. We confirmed P2Y2 expression
on THP-1 using flow cytometry (Figure 1(a)) and used a
functionalmeasure of P2Y2 receptors by intracellular calcium
measurements in response to a range of P2Y2 nucleotide ago-
nists, ATP, UTP, 2-thio-UTP, UTP𝛾S, and UDP (Figures 1(b)
and 1(c)). A concentration-response curve was generated for
UTP-induced calcium responses on THP-1 cells (Figure 1(d)).
Calcium responses were reduced in the presence of suramin
(100 𝜇M), a broad P2 receptor antagonist known to block
P2Y2 responses (Figure 1(b)).
We then stimulated THP-1 cells with the nucleotides UTP
and ATP𝛾S to stimulate P2Y2, or with LPS (1–10𝜇g/mL)
to induce CCL2 chemokine production and secretion. We
determined the amount of CCL2 secreted at three separate
timepoints: 2 hours, 6 hours, and 24 hours (Figure 2). We
found that UTP and ATP𝛾S were as effective as LPS at
stimulating CCL2 secretion after 2 hours. After 6 hours the
UTP or ATP𝛾S-induced CCL2 secretion remained elevated
above basal and again was not significantly different to
LPS. However, after 24 hours of stimulation there was a
further increase in the LPS-induced CCL2 secretion, while
the UTP or ATP𝛾S-induced CCL2 secretion remained low
(Figure 2). We decided to study the 2-hour timepoint to
further investigate nucleotide-induced CCL2 secretion. A
range of different nucleotide agonists were tested and many
increased CCL2 levels above background levels (Figure 3).
However, we found that only UTP or LPS treatments gave a
significant difference compared to basal (one-way ANOVA
with Dunnett’s post hoc test, 𝑛 = 3-4 experiments). The UTP
signal was not blocked by suramin, a feature also observed
when concentrations of UTP higher than 100 nM were used
in calcium responses in THP-1 cells (data not shown). Using
the THP-1 cell line we looked at CCL2 gene induction by
UTP in comparison to LPS. We used quantitative real-time
PCR and measured CCL2 relative to 𝛽-actin as the reference
gene at 2 hours following stimulation with LPS, UTP, UDP, or
media alone.We found thatUTP induced an 8.8-fold increase
in CCL2 expression compared to an 11-fold upregulation of
CCL2 in response to LPS (Figure 4). In contrast UDP did not
induce a significant upregulation of CCL2 levels (Figure 4).
As expected, LPS induced other chemokines CCL20 (459-
fold above media control) and CXCL8 (1121-fold abovemedia
control) in THP-1 cells, whereas UTP treatment induced a
4.1-fold upregulation of CCL20 and a 2.3-fold upregulation of
CCL3 with respect to unstimulated cells. UTP induced some
upregulation of CXCL8 expression (61-fold) but this was only
5% of the LPS response (1121-fold).
3.2. CCL2 Production in CD14+ Primary Human Monocytes.
Following our observations that UTP could induce a similar
level of CCL2 secretion as LPS in the THP-1 monocytic
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Figure 1: Nucleotides induce intracellular calcium responses in THP-1 cells. (a) Representative plot showing P2Y2 expression on THP-1
monocytes using a specific anti-P2Y2 antibody and a BD FACSCalibur flow cytometer. (b) THP-1 cells were loaded with Fluo-4 using a NW
kit and plated at 2 × 105 cells/well in poly-D-lysine coated 96-well plates. Intracellular calcium responses weremeasured using a BMGLabtech
Fluostar Optima plate reader for over 60 seconds at 37∘C. Responses to 100 nM ATP, 50 nMUTP, 50 nM 2-thio-UTP, and 250 nMUTP𝛾S are
shown in black. Paired responses of cells pretreated with the P2 receptor antagonist suramin (30𝜇M; 30 minutes) are shown in red. (c) Mean
calcium response data from several experiments. (d) A concentration-response curve was generated for UTP-induced calcium responses on
THP-1 cells. Mean responses ± SEM are plotted from 4 separate experiments.
cell line, we wanted to address whether this was also a
feature of primary human monocytes. We probed CD14-
positive PBMCs for P2Y2 expression and found significant
labelling relative to a nonspecific IgG control (Figure 5(a)).
To assess the functionality of P2Y2 receptors onmagnetically
isolated CD14 positive monocytes we performed calcium
measurements on Fluo-4AM loaded cells. UTP at both 10 𝜇M
and 100 𝜇M induced large transient calcium responses in
primary monocytes (Figure 5(b)).
We stimulated human CD14+ monocytes with media,
UTP (10 𝜇M), or LPS (100 ng/mL) for 4 hours (𝑛 = 11
different donors). When analysing the data as collective,
we found a small increase in CCL2 in response to LPS
(mean 376±88 pg/mL) above background CCL2 secretion in
media alone (mean 223±56 pg/mL).There was no difference
above background with 10 𝜇M UTP treatment (mean 215 ±
51 pg/mL) (Figure 5(c)). When looking at each individual
donor we could see that in 4 out of 11 subjects UTP increased
CCL2 levels above media alone treated cells. Subtracting the
background CCL2 concentration showed a UTP response
with a mean of 23 pg/mL (𝑛 = 4 subjects, range 8–49 pg/mL).
We then determined whether a longer incubation time of
6 hours would reveal an increased CCL2 secretory response
to UTP. When analysing the data as a collective, we found
a significant increase in CCL2 in response to LPS (mean
645 ± 55 pg/mL, 𝑛 = 5 donors, 𝑃 < 0.05 one-way ANOVA
withDunnett’s post hoc test) compared to background (mean
154 ± 55 pg/mL, 𝑛 = 5 donors). Treatment with 10 𝜇M UTP
(mean 134± 47 pg/mL) or 100𝜇MUTP (229± 72 pg/mL, 𝑛 =
5 donors) was not significantly different from background
CCL2 levels (Figure 5(d)). Again, when looking at each
subject we could see that all 5 donors responded to 100 𝜇M
UTP with CCL2 levels ranging from 19 to 129 pg/mL above
the basal secretion with a mean value of 76 pg/mL.
To determine whether we could measure CCL2 gene
induction in primary humanmonocytes we performed qPCR
analysis of CCL2 gene induction by UTP (100 𝜇M) and LPS
after a 6-hour stimulation. We found variable induction of
CCL2 andCCL20 in response to either UTP or LPS (Figure 6,
𝑛 = 3-4 donors).
3.3. Does P2Y2 Play a Role in CCL2 Secretion in Human
Macrophages? With such small responses to UTP in mono-
cytes and unstimulated THP-1monocytic cells, we decided to
differentiate THP-1 to macrophage-like cells using IFN-𝛾 and
LPS [20]. Our previousworkwas performed using an alveolar
macrophage cell line and peritoneal macrophages and mea-
sured robust CCL2 production [10]. IFN-𝛾/LPS differentiated
THP-1 cells (48-hour treatment) were stimulated with either
LPS, UTP, or media control and CCL2 was measured in
supernatants collected at 6 and 24 hours. Amuch higher basal
secretion of CCL2 was measured compared to unstimulated
THP-1 but both LPS and UTP could further increase CCL2
secretion at both timepoints (Figure 7).
To begin to address the variability in responses observed
with primary monocytes we focused on nonsynonymous
single nucleotide polymorphisms in P2Y2. There are three
known SNPs in human P2Y2 which may affect functional
responses [21, 22]. We first sequenced the P2Y2 gene from
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Figure 2: The effect of P2Y2 agonists compared with LPS on CCL2 secretion from unprimed THP-1 cells. THP-1 cells were plated in RPMI
media containing 1% serum and stimulated with media alone, LPS (1 or 10𝜇g/mL), UTP (10𝜇M), or ATP𝛾S (10𝜇M) for the times indicated
above each graph. Mean raw data is plotted in pg/mL ± SEM from three independent experiments. Symbols: ∗ denotes 𝑃 < 0.05 compared
with control, # denotes no significant difference between treatments, and ns denotes not significant with respect to control (one-way ANOVA
with Tukey’s post hoc test). Standard curves were performed for each ELISA experiment with fits of 𝑟 > 0.95.
THP-1 monocytes and found several synonymous SNPs and
a single nonsynonymous SNP (rs3741156) altering amino
acid 312 from arginine (R) to serine (S) (data not shown).
We developed an in-house genotyping assay based on restric-
tion enzyme analysis with MwoI. The presence of G or C at
position 1269 (NM 002564) correlates with a cut-site for this
enzyme. Wild-type individuals carrying G at this position
would show 3 fragments of 195, 130, and 3 bp, whereas
polymorphic individuals carrying C at this position would
show 4 fragments in the PCR restriction assay of 181, 130, 14,
and 3 bp (Figure 8(a)). We used this assay to genotype P2Y2
in healthy volunteers and confirmed the genotyping using
a custom high-throughput SNP assay (Australian Genome
Research Facility). From genotyping a total of 404 subjects we
determined an allele frequency of 0.276 for rs3741156 (𝑛 = 404
subjects).
We then performed a pilot study to investigate the effect of
genotype on chemokine secretion using individuals carrying
wild-type (WT) P2Y2 or 312S-P2Y2 receptors (5 subjects
per genotype). We stained PBMCs from WT and 312S-P2Y2
subjects for expression level of P2Y2 on CD14 positive cells
and found no significant difference in mean fluorescence
intensity (𝑛 = 3 donors/genotype) (Figure 8(b)). We cultured
adherent PBMCs to macrophages over 7 days to differentiate
monocytes to macrophages and stimulated cells with media,
10 𝜇M UTP, or 1 𝜇g/mL LPS for 4 hours (𝑛 = 5 donors
per genotype group). Supernatants were tested for CCL2
by ELISA and results are shown in Figure 9 as a scatter
graph. Responses to both LPS (mean 1054 ± 485 pg/mL) and
UTP (mean 882 ± 341 pg/mL) were smaller in WT-P2Y2
macrophages and not significantly different frombackground
CCL2 (mean 433 ± 181 pg/mL, 𝑛 = 5 donors). In contrast,
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Figure 3: Nucleotides induce CCL2 secretion fromTHP-1 cells after
2-hour stimulation. THP-1 cells were plated in RPMImedia contain-
ing 1% serum and stimulated withmedia alone, LPS (1 𝜇g/mL), UTP
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data is plotted in pg/mL ± SEM. Standard curves were performed
for each ELISA experiment with fits of 𝑟 > 0.95.
responses to LPS (mean 1411 ± 280 pg/mL) and UTP
(mean 1416 ± 401 pg/mL) were significantly different from
background CCL2 (mean 682 ± 271 pg/mL, 𝑛 = 5 donors,
one-way ANOVA with Dunnett’s post hoc test) in 312S-P2Y2
expressing macrophages.
4. Discussion
This study is the first to investigate UTP induced chemokine
secretion from THP-1 cells and primary human monocytes
and macrophages. Our main finding suggests that UTP can
elicit comparable levels of CCL2 as stimulation with the
bacterial product LPS in THP-1 cells. We also found that
macrophages produce more CCL2 in response to nucleotides
than monocytes even though levels of P2Y2 expression are
similar.
It is well known in the literature that monocytes and
macrophages express P2Y2 receptors amongst other P2Y and
P2X receptors [3, 4, 11, 13]. Here we confirm expression of
P2Y2 in THP-1 cells using flow cytometry and intracellular
calcium measurements as an indirect measure of G protein-
coupled receptor activation (Figure 1). The pharmacology
for this receptor is relatively poor compared with other
purinergic receptors. Several pieces of evidence suggest that
the UTP-induced response in THP-1 cells is due to P2Y2
activation. UTP is only known to activate P2Y2, P2Y4, and
P2Y6 receptors [23], and, of these, the only receptor respon-
sive to ATP is P2Y2. ATP and UTP are equipotent at P2Y2
receptors and EC
50
values for UTP andATP-induced calcium
responses were 97 ± 34 nM and 105 ± 59 nM, respectively, in
THP-1 cells. Suramin could suppress UTP and ATP-induced
calcium responses as well as the response elicited by UTP𝛾S
(Figure 1). However, suramin did not suppress responses
induced by the P2Y2-selective agonist 2-thio-UTP (Figure 1).
Furthermore, we found that suramin could not suppress
calcium responses induced by high concentrations (>1𝜇M)
of nucleotides and as such we did not use suramin in the
subsequent CCL2 experiments.
The calcium experiments were used as an indication
that functional P2Y receptors were present on THP-1 cells
and we found that the P2Y6 receptor agonist UDP also
elicited a suramin-sensitive calcium response in THP-1 cells
(Figure 1). Whilst P2Y6 is likely expressed in THP-1 cells
as shown by Yebdri et al. [13], experiments with CCL2
secretion suggest that UDP did not have a significant our
effect (Figure 3). Furthermore, both UTP𝛾S (P2Y2 and P2Y4
selective agonist) and 2-thio-UTP (P2Y2 selective) could
induce CCL2 secretion above basal levels but not to the same
degree as UTP (full agonist at P2Y2).
A major aim of this study was to compare nucleotide-
induced chemokine secretion to a known proinflammatory
signal such as LPS. We chose the THP-1 cell line to perform
these experiments to limit variability in responses. The LPS-
induced CCL2 secretory response in THP-1 monocytes was
low (<100 pg/mL) at early timepoints such as 2 and 6 hours
but increased over a 24-hour treatment period (Figure 2).
The amount of constitutively produced CCL2 from THP-1
cells in our hands was similar to that measured by Steube
et al. [24]. Steube et al. observed a low level of CCL2
secretion from THP-1 in response to LPS compared to other
myelomonocytic cells lines [24]. This low constitutive CCL2
secretion is quite different from the high level of constitutive
CCL2 expression seen in NR8383 alveolar macrophages in
our previous study [10].
We compared the LPS-induced CCL2 response to that
of UTP and ATP𝛾S at concentrations known to induce
large calcium responses (10𝜇M) in THP-1 cells. At an early
timepoint, 2 hours, the nucleotide-induced CCL2 secretion
was comparable to LPS-induced CCL2 secretion (Figure 2).
However, the nucleotide-induced response remained stable
between 2 and 6 hours and the LPS-induced response steadily
increased over time. In primary human monocytes and
macrophages the kinetics of CCL2 production appeared to
be slower in response to either LPS or UTP (Figures 5 and
9). After 4–6 hours of stimulation the LPS-induced CCL2
response becomes significant above background CCL2 secre-
tion, whereas overall the UTP-induced response remains not
significantly elevated above basal levels (Figure 5). Thus in
primary human monocytes we observed a large difference
between the P2Y2-induced response and the LPS-induced
response. Several factors may influence this data including
genetic differences in membrane receptors, expression levels
of receptors at the plasma membrane, and differences in
intracellular signalling or in CCL2 mRNA stability. However,
in human monocyte-derived macrophages the UTP-induced
response was again similar to the LPS-induced response
(Figure 9) and this was also true in IFN/LPS differentiated
THP-1 macrophages after 6 hours (Figure 7).
We investigated whether nucleotides could also induce
production of other inflammatory chemokines such as
CCL20 (MIP-3𝛼), CCL3 (MIP-1𝛼), and CXCL8 (IL-8).
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Figure 4: UTP induces CCL2 gene transcription in THP-1 monocytes. THP-1 cells were plated in RPMI media containing 1% serum and
stimulated with media alone, LPS (1 𝜇g/mL), UTP (10𝜇M), or UDP (10 𝜇M) for 2 hours. RNA was extracted, reverse transcribed to cDNA,
and probed with quantitative PCR primers for chemokines (CCL2, CCL20, CCL3, and CXCL8) and reference genes (𝛽-actin and GAPDH).
PCR was performed in triplicate using a Rotorgene 2000. Data was analysed using the 2−ΔΔCt method using a threshold of 0.003.
Nucleotide-induced CCL20 production has been demon-
strated in human dendritic cells (UDP and ATP𝛾S) [9],
CXCL8 production in monocytes [13], and CCL3 production
in rodent microglia (UTP, UDP) [7]. Using quantitative PCR
we found that LPS upregulated both CCL20 and CXCL8
in THP-1 cells; however UTP had no significant effect
on CCL3, CCL20, and CXCL8 production (Figure 4). In
primary humanmonocytes LPS significantly induced CCL20
gene expression in all 4 donors (42–427-fold increase). In
comparison UTP and UDP nucleotides did not significantly
induce CCL20 (𝑛 = 4 donors). Our data shows that CCL2
induction in primary human CD14+ monocytes was variable
in response to either LPS or UTP (Figure 6) confirming our
variability in the protein secretion experiments.
The finding that UTP stimulation of P2Y2 receptors can
elicit a similar CCL2 chemokine response to LPS stimulation
of TLR4 is a novel finding andonewith potential relevance for
inflammation. UTP is a known danger signal, similar to ATP,
and is likely to be present in areas of tissue damage without
infection in addition to sites of infection. Such nucleotides
may be a driving factor in sterile inflammation and may
contribute to disease associated chronic inflammatory states.
It is also important to hypothesise about why nucleotidesmay
induce CCL2. In addition to the role of CCL2 as a chemokine
for immune cells, it may be released as a mechanism for
upregulating other receptors such as P2X4 receptors, as
recently described by Toyomitsu et al. [25]. CCL2 may there-
fore act as an autocrine factor on monocytes/macrophages to
prime further inflammatory signalling.
A secondmajor aimof the current studywas to investigate
P2Y2 induced chemokine production in primary human
monocytes and macrophages. We isolated monocytes from
peripheral blood of a number of donors to determine
if the nucleotide-induced CCL2 response was detectable.
Our data demonstrates a degree of variability in constitu-
tive and induced secretion of CCL2 from monocytes and
macrophages. This type of variability has been observed pre-
viously for LPSwhere different individuals can be classified as
high or low responders [26] and other studies have demon-
strated variable LPS-induced responses including interleukin
1𝛽 (IL-1𝛽) secretion [27] and CCL20 chemokine secretion
from human dendritic cells and monocytes [9]. We and
others have also previously shown variability in IL-1𝛽 secre-
tion in response to P2X7 activation [19, 28]. One source
of such variability in responses is genetic variation in the
form of single nucleotide polymorphisms and three SNPs
have been identified in the human P2RY2 gene [21, 22].
Sequencing determined that one SNP, rs3741156, was present
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Figure 5: Primary human peripheral blood monocytes express P2Y2 but display variable CCL2 secretion to UTP. (a) Human PBMCs were
labelled with conjugated CD14-FITC and rabbit anti-P2Y2 followed by goat anti-rabbit Alexa 647 using an intracellular staining protocol.
(b) Human CD14 positive magnetically isolated monocytes were plated on poly-D-lysine plates and loaded with Fluo-4AM. UTP induced a
transient calcium response at both 10 𝜇M (orange) and 100 𝜇M (blue). Calcium measurements were recorded using a Fluostar Optima plate
reader at 37∘C. (c) Human CD14+ monocytes were plated at 5 × 105 cells/well and stimulated with media, LPS 100 ng/mL, or 10𝜇MUTP for
4 hours. Each symbol represents a different donor (𝑛 = 11 donors in total). (d) Human CD14+ monocytes stimulated for 6 hours with media,
LPS 100 ng/mL, 10 𝜇MUTP, or 100𝜇MUTP. Each symbol represents a different donor (𝑛 = 5 different donors).
in the THP-1 cell line and other studies have demonstrated
that this mutation altering amino acid 312 can affect UTP-
induced calcium responses in transfected cells [21]. Other
studies have indicated that P2Y induced calcium signalling
is important in switching on CCL2 production in myeloid
cells [7]. Monocyte-derived macrophages from individuals
carrying the 312Ser-P2Y2 variant displayed a significant
CCL2 secretory response compared to individuals expressing
a 312Arg-containing receptor (Figure 9). Therefore, SNPs
in P2Y2 may correlate with variability in responses. Future
studies will investigate if other SNPs are present in the
gene and whether they have a functional effect on receptor
signalling.
5. Conclusions
Nucleotides are effective inducers of the chemokine CCL2
fromTHP-1monocytic cell line similar to lipopolysaccharide.
10 Mediators of Inflammation
CCL2 CCL20 CCL3
0
1
2
3
4
5
Fo
ld
 u
pr
eg
ul
at
io
n/
re
fe
re
nc
e g
en
e
CCL2 CCL20 CCL3 CXCL8
0
20
40
60
80
100
100
200
300
400
500
Fo
ld
 u
pr
eg
ul
at
io
n/
re
fe
re
nc
e g
en
e
UTP LPS
CXCL8
Figure 6: UTP induces chemokine gene transcription in human monocytes. Human CD14+ monocytes were plated in RPMI media
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Figure 7: IFN/LPS differentiated THP-1 macrophages display increased CCL2 production to LPS or UTP. THP-1 cells were plated in RPMI
media containing 10% serum and stimulated with IFN-𝛾 and LPS for 48 hours. Media were removed and cells were challenged with either
media alone (control), LPS (1 𝜇g/mL), UTP (10𝜇M), or UTP (100 𝜇M) for 4 hours. Mean raw data is plotted in pg/mL ± SEM. Standard curves
were performed for each ELISA experiment with fits of 𝑟 > 0.95.
Human primary macrophages display a more robust CCL2
response to nucleotides than human monocytes. Some of
the variability in the CCL2 response to nucleotides could
be explained by genetic variation in the P2Y2 gene with a
mutation altering amino acid 312 demonstrating an increased
chemokine response.
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